Beyond phenotype: The genomic heterogeneity of co-infecting Mycobacterium abscessus smooth and rough colony variants in cystic fibrosis patients

Lopeman, 2019, Mycobacterium abscessus: environmental Bacterium Turned Clinical Nightmare, Microorganisms, 7, 10.3390/microorganisms7030090 Ripoll, 2007, Genomics of glycopeptidolipid biosynthesis in Mycobacterium abscessus and M. chelonae, BMC Genomics., 8, 114, 10.1186/1471-2164-8-114 Park, 2015, Clonal Diversification and Changes in Lipid Traits and Colony Morphology in Mycobacterium abscessus Clinical Isolates, J Clin Microbiol, 53, 3438, 10.1128/JCM.02015-15 Pawlik, 2013, Identification and characterization of the genetic changes responsible for the characteristic smooth-to-rough morphotype alterations of clinically persistent Mycobacterium abscessus, Mol Microbiol, 90, 612, 10.1111/mmi.12387 Rüger, 2014, Characterization of rough and smooth morphotypes of Mycobacterium abscessus isolates from clinical specimens, J Clin Microbiol, 52, 244, 10.1128/JCM.01249-13 Shaw, 2019, Children With Cystic Fibrosis Are Infected With Multiple Subpopulations of Mycobacterium abscessus With Different Antimicrobial Resistance Profiles, Clin Infect Dis, 69, 1678, 10.1093/cid/ciz069 Besra, 1998, Preparation of cell-wall fractions from mycobacteria, Methods Mol Biol, 101, 91 Bankevich, 2012, SPAdes: a new genome assembly algorithm and its applications to single-cell sequencing, J Comput Biol, 19, 455, 10.1089/cmb.2012.0021 Seemann, 2014, Prokka: rapid prokaryotic genome annotation, Bioinformatics, 30, 2068, 10.1093/bioinformatics/btu153 Okonechnikov, 2012, Unipro UGENE: a unified bioinformatics toolkit, Bioinformatics, 28, 1166, 10.1093/bioinformatics/bts091 Hadfield, 2018, Phandango: an interactive viewer for bacterial population genomics, Bioinformatics, 34, 292, 10.1093/bioinformatics/btx610 Wallace, 1996, Genetic basis for clarithromycin resistance among isolates of Mycobacterium chelonae and Mycobacterium abscessus, Antimicrob Agents Chemother, 40, 1676, 10.1128/AAC.40.7.1676 Kim, 2010, Mycobacterium massiliense is differentiated from Mycobacterium abscessus and Mycobacterium bolletii by erythromycin ribosome methyltransferase gene (erm) and clarithromycin susceptibility patterns, Microbiol Immunol, 54, 347, 10.1111/j.1348-0421.2010.00221.x Bastian, 2011, Assessment of clarithromycin susceptibility in strains belonging to the Mycobacterium abscessus group by erm(41) and rrl sequencing, Antimicrob Agents Chemother, 55, 775, 10.1128/AAC.00861-10 Lee, 2014, The drug resistance profile of Mycobacterium abscessus group strains from Korea, Ann Lab Med, 34, 31, 10.3343/alm.2014.34.1.31 Howard, 2006, Spontaneous reversion of Mycobacterium abscessus from a smooth to a rough morphotype is associated with reduced expression of glycopeptidolipid and reacquisition of an invasive phenotype, Microbiology (Reading, Engl), 152, 1581, 10.1099/mic.0.28625-0 Tsai, 2015, Subinhibitory Doses of Aminoglycoside Antibiotics Induce Changes in the Phenotype of Mycobacterium abscessus, Antimicrob Agents Chemother, 59, 6161, 10.1128/AAC.01132-15 Bernut, 2017, The Diverse Cellular and Animal Models to Decipher the Physiopathological Traits of Mycobacterium abscessus Infection, Front Cell Infect Microbiol, 7, 100, 10.3389/fcimb.2017.00100 Mushatt, 1995, Successful treatment of Mycobacterium abscessus infections with multidrug regimens containing clarithromycin, Clin Infect Dis, 20, 1441, 10.1093/clinids/20.5.1441 Nash, 2009, A novel gene, erm(41), confers inducible macrolide resistance to clinical isolates of Mycobacterium abscessus but is absent from Mycobacterium chelonae, Antimicrob Agents Chemother, 53, 1367, 10.1128/AAC.01275-08 Malcolm, 2018, Neutrophil killing of Mycobacterium abscessus by intra- and extracellular mechanisms, PLoS ONE, 13, 10.1371/journal.pone.0196120